{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:43:31Z","timestamp":1780497811955,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["219551\/Z\/19\/Z"],"award-info":[{"award-number":["219551\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcf.2022.07.009","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T23:55:31Z","timestamp":1658447731000},"page":"320-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samples"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-3611","authenticated-orcid":false,"given":"Dominic A","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-2269","authenticated-orcid":false,"given":"Leah","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Newara","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imogen","family":"Felton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1705-4780","authenticated-orcid":false,"given":"Nicholas J","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Loebinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0756-0652","authenticated-orcid":false,"given":"Henry","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Armstrong-James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Stuart","family":"Elborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7623-5840","authenticated-orcid":false,"given":"Miriam F","family":"Moffatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3506-1199","authenticated-orcid":false,"given":"Jane C","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcf.2022.07.009_bib0001","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13693780802609604","article-title":"Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis\u2013a review","volume":"47","author":"Pihet","year":"2009","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.jcf.2022.07.009_bib0002","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.09-1103","article-title":"The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis","volume":"137","author":"Amin","year":"2010","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jcf.2022.07.009_bib0003","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1164\/rccm.201908-1585OC","article-title":"Aspergillus infections and progression of structural lung disease in children with cystic fibrosis","volume":"201","author":"Breuer","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2022.07.009_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcf.2019.08.008","article-title":"The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis","volume":"19","author":"Hong","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2022.07.009_bib0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jcf.2021.04.007","article-title":"Clinical characteristics of Pseudomonas and Aspergillus co-infected cystic fibrosis patients: a UK registry study","volume":"21","author":"Hughes","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2022.07.009_bib0006","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12890-017-0416-4","article-title":"Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis","volume":"17","author":"Reece","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"10","key":"10.1016\/j.jcf.2022.07.009_bib0007","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1164\/rccm.201203-0478OC","article-title":"The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis","volume":"186","author":"Coughlan","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jcf.2022.07.009_bib0008","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s10096-011-1229-7","article-title":"A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility","volume":"30","author":"Mortensen","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.jcf.2022.07.009_bib0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2213-2600(18)30171-1","article-title":"The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial","volume":"6","author":"Ronchetti","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.jcf.2022.07.009_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/adc.2003.037481","article-title":"Cough plate versus cough swab in patients with cystic fibrosis; a pilot study","volume":"89","author":"Maiya","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2022.07.009_bib0011","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fmicb.2018.00531","article-title":"Performance of molecular approaches for Aspergillus detection and azole resistance surveillance in cystic fibrosis","volume":"9","author":"Guegan","year":"2018","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.jcf.2022.07.009_bib0012","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcf.2007.06.006","article-title":"Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis","volume":"7","author":"Valenza","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2022.07.009_bib0013","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2013.04.007","article-title":"Novel immunologic classification of aspergillosis in adult cystic fibrosis","volume":"132","author":"Baxter","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcf.2022.07.009_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2019.105683","article-title":"The prevalence of Aspergillus fumigatus in early cystic fibrosis disease is underestimated by culture-based diagnostic methods","volume":"164","author":"Reece","year":"2019","journal-title":"J Microbiol Methods"},{"issue":"1","key":"10.1016\/j.jcf.2022.07.009_bib0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mimet.2011.01.024","article-title":"Homogenisation of cystic fibrosis sputum by sonication\u2013an essential step for Aspergillus PCR","volume":"85","author":"Baxter","year":"2011","journal-title":"J Microbiol Methods"},{"issue":"2","key":"10.1016\/j.jcf.2022.07.009_bib0016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2022.07.009_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/jof5020048","article-title":"Interactions between Aspergillus fumigatus and pulmonary bacteria: current state of the field, new data, and future perspective","volume":"5","author":"Briard","year":"2019","journal-title":"J Fungi"},{"issue":"4","key":"10.1016\/j.jcf.2022.07.009_bib0018","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41591-021-01289-7","article-title":"Integrative microbiomics in bronchiectasis exacerbations","volume":"27","author":"Mac Aogain","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jcf.2022.07.009_bib0019","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcf.2020.05.013","article-title":"The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"20","author":"Cuthbertson","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.07.009_bib0020","unstructured":"C.F. Trust. Laboratory standards for processing microbiological samples from people with cystic fibrosis on behalf of The UK Cystic Fibrosis Trust Microbiology Laboratory Standards Working Group. 2010 10th March 2021; 1st Edition. Available from: https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2020-12\/Laboratory%20standards.pdf."},{"issue":"5","key":"10.1016\/j.jcf.2022.07.009_bib0021","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1139\/cjm-2016-0705","article-title":"Synthetic cystic fibrosis sputum medium diminishes Burkholderia cenocepacia antifungal activity against Aspergillus fumigatus independently of phenylacetic acid production","volume":"63","author":"Lightly","year":"2017","journal-title":"Can J Microbiol"},{"issue":"4","key":"10.1016\/j.jcf.2022.07.009_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00855-19","article-title":"Cooperativity between stenotrophomonas maltophilia and Pseudomonas aeruginosa during polymicrobial airway infections","volume":"88","author":"McDaniel","year":"2020","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.jcf.2022.07.009_bib0023","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41396-021-01130-6","article-title":"Inter-species interactions alter antibiotic efficacy in bacterial communities","volume":"16","author":"Bottery","year":"2022","journal-title":"ISME J"},{"key":"10.1016\/j.jcf.2022.07.009_bib0024","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fcimb.2017.00106","article-title":"In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp","volume":"7","author":"Hotterbeekx","year":"2017","journal-title":"Front Cell Infect Microbiol."},{"issue":"8","key":"10.1016\/j.jcf.2022.07.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134692","article-title":"Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa is dependent on the source, phenotype and growth conditions of the bacterium","volume":"10","author":"Ferreira","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jcf.2022.07.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00345-17","article-title":"Studies of Pseudomonas aeruginosa mutants indicate pyoverdine as the central factor in inhibition of Aspergillus fumigatus biofilm","volume":"200","author":"Sass","year":"2018","journal-title":"J Bacteriol"},{"issue":"8","key":"10.1016\/j.jcf.2022.07.009_bib0027","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41564-018-0191-x","article-title":"The type VI secretion system deploys antifungal effectors against microbial competitors","volume":"3","author":"Trunk","year":"2018","journal-title":"Nat Microbiol"},{"issue":"2","key":"10.1016\/j.jcf.2022.07.009_bib0028","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcf.2018.10.001","article-title":"Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: results from the international prospective study \"MFIP\"","volume":"18","author":"Delhaes","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2022.07.009_bib0029","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/JCM.38.4.1510-1515.2000","article-title":"Identification of Aspergillus species using internal transcribed spacer regions 1 and 2","volume":"38","author":"Henry","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.jcf.2022.07.009_bib0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/JCM.02214-15","article-title":"Detection of airway colonization by Aspergillus fumigatus by use of electronic nose technology in patients with cystic fibrosis","volume":"54","author":"de Heer","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.jcf.2022.07.009_bib0031","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2017-210394","article-title":"Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor","volume":"73","author":"Bessonova","year":"2018","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jcf.2022.07.009_bib0032","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/CMR.00068-09","article-title":"The changing microbial epidemiology in cystic fibrosis","volume":"23","author":"Lipuma","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcf.2022.07.009_bib0033","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13756-019-0521-7","article-title":"In vitro polymyxin activity against clinical multidrug-resistant fungi","volume":"8","author":"Yousfi","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"10.1016\/j.jcf.2022.07.009_bib0034","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/microorganisms8091447","article-title":"Colistin and isavuconazole interact synergistically in vitro against Aspergillus nidulans and Aspergillus niger","volume":"8","author":"Schwarz","year":"2020","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.jcf.2022.07.009_bib0035","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/thoraxjnl-2018-211548","article-title":"Australasian cystic fibrosis bronchoalveolar lavage study g. Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis","volume":"74","author":"Harun","year":"2019","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jcf.2022.07.009_bib0036","doi-asserted-by":"crossref","first-page":"18999","DOI":"10.1038\/s41598-020-75886-w","article-title":"Risk factors for respiratory Aspergillus fumigatus in German cystic fibrosis patients and impact on lung function","volume":"10","author":"Duesberg","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jcf.2022.07.009_bib0037","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/314727","article-title":"Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis","volume":"179","author":"Burns","year":"1999","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.jcf.2022.07.009_bib0038","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0954-6111(99)90270-6","article-title":"Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients","volume":"93","author":"Bargon","year":"1999","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.jcf.2022.07.009_bib0039","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcf.2018.01.008","article-title":"Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis","volume":"17","author":"Hong","year":"2018","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322006270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322006270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:47:53Z","timestamp":1761601673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199322006270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1569199322006270"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2022.07.009","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samples","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}